{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T13:46:25Z","timestamp":1781358385593,"version":"3.54.1"},"reference-count":33,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK098566"],"award-info":[{"award-number":["DK098566"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cell. Physiol."],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1002\/jcp.25458","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T11:17:08Z","timestamp":1466075828000},"page":"610-616","source":"Crossref","is-referenced-by-count":16,"title":["FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice"],"prefix":"10.1002","volume":"232","author":[{"given":"E.","family":"Du","sequence":"first","affiliation":[{"name":"Department of Medicine; University of Connecticut Health Center; Farmington Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Connecticut Health Center; Farmington Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Hurley","sequence":"additional","affiliation":[{"name":"Department of Medicine; University of Connecticut Health Center; Farmington Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"key":"10.1002\/jcp.25458-BIB0001|jcp25458-cit-0001","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1002\/jcp.25458-BIB0002|jcp25458-cit-0002","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1091\/mbc.10.5.1429","article-title":"Nuclear activities of basic fibroblast growth factor: Potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals","volume":"10","author":"Arese","year":"1999","journal-title":"Mol Biol Cell"},{"key":"10.1002\/jcp.25458-BIB0003|jcp25458-cit-0003","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1002\/jcp.25458-BIB0004|jcp25458-cit-0004","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.med.051308.111339","article-title":"Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23","volume":"61","author":"Bergwitz","year":"2010","journal-title":"Ann Rev Med"},{"key":"10.1002\/jcp.25458-BIB0005|jcp25458-cit-0005","first-page":"26","article-title":"Biological roles of fibroblast growth factor-2","volume":"18","author":"Bikfalvi","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1002\/jcp.25458-BIB0006|jcp25458-cit-0006","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00018-008-8440-4","article-title":"High molecular weight FGF2: The biology of a nuclear growth factor","volume":"66","author":"Chlebova","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1002\/jcp.25458-BIB0007|jcp25458-cit-0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2016.08.006","article-title":"FGFR inhibitor ameliorates hypophosphatemia and impaired engrailed-1\/Wnt signaling in FGF2 high molecular weight isoform transgenic mice","volume":"9999","author":"Du","year":"2016","journal-title":"J Cell Biochem"},{"key":"10.1002\/jcp.25458-BIB0008|jcp25458-cit-0008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1677\/JOE-10-0181","article-title":"Altered renal FGF23-mediated activity involving MAPK and Wnt: Effects of the Hyp mutation","volume":"207","author":"Farrow","year":"2010","journal-title":"J Endocrinol"},{"key":"10.1002\/jcp.25458-BIB0009|jcp25458-cit-0009","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1073\/pnas.86.11.3978","article-title":"Human basic fibroblast growth factor gene encodes four polypeptides: Three initiate translation from non-AUG codons","volume":"86","author":"Florkiewicz","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/jcp.25458-BIB0010|jcp25458-cit-0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The hyp consortium","volume":"11","author":"Francis","year":"1995","journal-title":"Nat Genet"},{"key":"10.1002\/jcp.25458-BIB0011|jcp25458-cit-0011","doi-asserted-by":"crossref","first-page":"36303","DOI":"10.1074\/jbc.M114.619569","article-title":"Knockout of nuclear high molecular weight FGF2 isoforms in mice modulates bone and phosphate homeostasis","volume":"289","author":"Homer-Bouthiette","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1002\/jcp.25458-BIB0012|jcp25458-cit-0012","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/B978-012098652-1\/50149-9","volume-title":"Principles of bone biology","author":"Hurley","year":"2002"},{"key":"10.1002\/jcp.25458-BIB0013|jcp25458-cit-0013","first-page":"599","article-title":"Accelerated fracture healing in transgenic mice overexpressing an anabolic isoform of fibroblast growth factor 2","volume":"117","author":"Hurley","year":"2016","journal-title":"J Cell Bio Chem"},{"key":"10.1002\/jcp.25458-BIB0014|jcp25458-cit-0014","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1 I collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1002\/jcp.25458-BIB0015|jcp25458-cit-0015","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nat Genet"},{"key":"10.1002\/jcp.25458-BIB0016|jcp25458-cit-0016","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3904\/kjim.2011.26.2.113","article-title":"Klotho and the aging process","volume":"26","author":"Kuro-o","year":"2011","journal-title":"Korean J Intern Med"},{"key":"10.1002\/jcp.25458-BIB0017|jcp25458-cit-0017","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1172\/JCI8641","article-title":"Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation","volume":"105","author":"Montero","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1002\/jcp.25458-BIB0018|jcp25458-cit-0018","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1002\/jcp.25458-BIB0019|jcp25458-cit-0019","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1002\/jcp.25458-BIB0020|jcp25458-cit-0020","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1002\/jcp.25458-BIB0021|jcp25458-cit-0021","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/978-1-4614-0887-1_10","article-title":"FGF23 as a novel therapeutic target","volume":"728","author":"Shimada","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"10.1002\/jcp.25458-BIB0022|jcp25458-cit-0022","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1172\/JCI64986","article-title":"Circulating \u03b1Klotho influences phosphate handling by controlling FGF23 production","volume":"122","author":"Smith","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1002\/jcp.25458-BIB0023|jcp25458-cit-0023","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jcb.20389","article-title":"Overexpression of fibroblast growth factor-2 causes defective bone mineralization and osteopenia in transgenic mice","volume":"95","author":"Sobue","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1002\/jcp.25458-BIB0024|jcp25458-cit-0024","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.1038\/srep08304","article-title":"FGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice","volume":"10","author":"Sun","year":"2015","journal-title":"Sci Rep"},{"key":"10.1002\/jcp.25458-BIB0025|jcp25458-cit-0025","doi-asserted-by":"crossref","unstructured":"Autosomal dominant hypophosphataemic rickets is associated with mutations in F GF23 Nat Genet 26 345 348","DOI":"10.1038\/81664"},{"key":"10.1002\/jcp.25458-BIB0026|jcp25458-cit-0026","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1002\/jcp.25458-BIB0027|jcp25458-cit-0027","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1074\/jbc.M804900200","article-title":"Exported 18-kDa isoform of fibroblast growth factor-2 is a critical determinant of bone mass in mice","volume":"284","author":"Xiao","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1002\/jcp.25458-BIB0028|jcp25458-cit-0028","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1074\/jbc.M109.030577","article-title":"Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO","volume":"285","author":"Xiao","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1002\/jcp.25458-BIB0029|jcp25458-cit-0029","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jbmr.1721","article-title":"Nuclear fibroblast growth factor 2 FGF2 isoforms inhibit bone marrow stromal cell mineralization through FGF23\/FGFR\/MAPK in vitro","volume":"28","author":"Xiao","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1002\/jcp.25458-BIB0030|jcp25458-cit-0030","doi-asserted-by":"crossref","first-page":"28265","DOI":"10.1074\/jbc.M202527200","article-title":"Fibroblast growth factor FGF-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway","volume":"277","author":"Yamashita","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1002\/jcp.25458-BIB0031|jcp25458-cit-0031","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1359\/jbmr.080417","article-title":"Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23","volume":"23","author":"Yamazaki","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1002\/jcp.25458-BIB0032|jcp25458-cit-0032","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cytogfr.2005.01.002","article-title":"FGF23 and disorders of phosphate homeostasis","volume":"16","author":"Yu","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1002\/jcp.25458-BIB0033|jcp25458-cit-0033","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/jbmr.294","article-title":"Unique roles of phosphorus in endochondral bone formation and osteocyte maturation","volume":"26","author":"Zhang","year":"2011","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Cellular Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcp.25458","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcp.25458","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcp.25458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:16:08Z","timestamp":1625310968000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcp.25458"}},"subtitle":["FGF23AB AMELIORATES HMWFGF2 HYPOPHOSPHATEMIA"],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"URL":"https:\/\/doi.org\/10.1002\/jcp.25458","archive":["Portico"],"relation":{},"ISSN":["0021-9541"],"issn-type":[{"value":"0021-9541","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6,30]]}}}